OTC - ACTIVE INGREDIENT SECTION
Kali Phos 30X
Kali Phos 30X
Lactose
Stop use and ask doctor if symptoms worsen or persist longer than 7 days.
Do not use if tamper evident seal is missing or broken.
Temporary relief fatigue, weakness, exhaustion.
Temporary relief fatigue, weakness, exhaustion.
Adults and children 12 years of age and older: Four tablets every thirty minutes for six doses followed by four tablets every 4-6 hours as needed.
Children 2 years to 12 years of age: Four tablets every thirty minutes for six doses followed by two tablets every 4-6 hours as needed.
Children under 2 years of age: Consult doctor prior to use.
Keep out of reach of children.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 79718-0029-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-fed1-a426-e053-dadaa90af4c2 | b2b13134-d170-b7dd-e053-2995a90a8112 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79718-0029-1 | Kali Phos 30X | 100 in 1 JAR | TABLET | 100 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 79718-0029 | KALI PHOS 30X TABLET [WARSAN HOMEOPATHIC] | 1 | Legacy NDC, 1 package rows | 20201110_b2b13134-d170-b7dd-e053-2995a90a8112.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 79718-0029 | 79718-0029-1 |
| 79769-0029 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| POTASSIUM PHOSPHATE, UNSPECIFIED FORM | B7862WZ632 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b2b13707-2dba-6fa6-e053-2a95a90a9ce8 | b2b13134-d170-b7dd-e053-2995a90a8112 | 2020-10-27 | Warnings | b2b13707-2dba-6fa6-e053-2a95a90a9ce8 b2b13134-d170-b7dd-e053-2995a90a8112 |
Adverse event summaries are temporarily unavailable. Other product information remains available.